key: cord-0021927-919qrfs0
authors: Zhou, Yi; Tan, Zhi; Huang, Hao; Zeng, Yonglian; Chen, Shilian; Wei, Jie; Huang, Guozhen; Qian, Chaosi; Yuan, Guandou; He, Songqing
title: Baicalein pre-treatment alleviates hepatic ischemia/reperfusion injury in mice by regulating the Nrf2/ARE pathway
date: 2021-09-28
journal: Exp Ther Med
DOI: 10.3892/etm.2021.10816
sha: a5d3901dfcf84a5ba73276251e6e1da36ba3ab52
doc_id: 21927
cord_uid: 919qrfs0

Hepatic ischemia-reperfusion injury (HIRI) is caused by blood flow recovery following ischemia. Baicalein (BAI), a natural antioxidant used in traditional Chinese medicine, eliminates excessive free radicals and protects the structure of the cell membrane. However, its protective mechanism against HIRI is still unclear. The present study investigated underlying mechanism using a mouse HIRI model. Liver injury was evaluated using serum levels of alanine aminotransferase and aspartate aminotransferase, and hematoxylin-eosin staining was performed to evaluate the pathological changes in liver tissue. Apoptosis of hepatocytes was detected by TUNEL staining. The expression levels of reactive oxygen species (ROS), malondialdehyde (MDA) and superoxide dismutase (SOD) in the liver were detected to evaluate oxidative stress. Western blotting was performed to assess expression levels of nuclear factor E2-related factor 2 (Nrf2)/antioxidant response elements (ARE) pathway proteins in liver tissue. BAI pre-treatment significantly decreased elevation of serum aminotransferase levels induced by IR and alleviated histological damage to the liver. BAI decreased production of ROS and MDA in liver tissue induced by IR and increased the activity of SOD. At the same time, BAI inhibited apoptosis of liver cells induced by oxidative stress. Furthermore, BAI promoted the translocation of Nrf2 into the nucleus and increased the expression of total heme oxygenase-1 and NAD(P)H dehydrogenase quinone-1. The Nrf2 inhibitor ML385 reversed the protective effect of BAI on HIRI. These results indicated that BAI served a protective effect in HIRI by regulating the Nrf2/ARE pathway.

Hepatic ischemia-reperfusion injury (HIRI) occurs in hepatectomy, severe liver trauma surgery and liver transplantation (1) . It results in postoperative liver dysfunction and failure (2) . Reactive oxygen species (ROS) are one of the key factors influencing HIRI (3, 4) . ROS are continuously produced during hepatic ischemia-reperfusion and excessive levels ROS damage hepatocytes (5, 6) . In response to ROS damage, liver cells undergo inflammation and apoptosis (7) . The liver forms a complex oxidative stress response system and upregulates expression levels of protective genes, such as heme oxygenase-1 (HO-1), to decrease injury to hepatocytes when exposed to ROS (8) . Previous studies have shown that pre-treatment drugs, such as sulforaphane and baicalein (BAI), can also regulate the antioxidant pathway in the liver (9, 10) .

BAI is one of the most abundant flavonoids and the primary active component of Scutellaria baicalensis (11, 12) . Previous studies have confirmed that BAI has anti-bacterial, ROS scavenging, anti-inflammatory and anti-tumor effects (13) (14) (15) (16) . Moreover, accumulated data have shown that BAI protects against several types of liver disease, such as alcoholic liver disease (17) , non-alcoholic fatty liver disease (18, 19) , chemical-induced liver fibrosis (20) and immunological liver injury (21) . Although certain studies by Liu et al (22, 23) addressed the beneficial effects of BAI on HIRI, no in vivo study has determined the mechanism underlying the protective effects of BAI on HIRI via the nuclear factor E2-related factor 2 (Nrf2)/antioxidant response element (ARE) pathway.

Nrf2 has been found to regulate antioxidant proteins by interacting with ARE, which is a key endogenous antioxidant stress pathway (9) . There are >200 coding endogenous protective genes regulated by the Nrf2/ARE signaling pathway (1). These protective genes include antioxidant and phase II Baicalein pre-treatment alleviates hepatic ischemia/reperfusion injury in mice by regulating the Nrf2/ARE pathway detoxification enzymes, such as catalase, HO-1, superoxide dismutase (SOD), and NAD(P)H dehydrogenase quinone (NQO)-1 and -2 (24) (25) (26) . According to previous studies, the Nrf2/ARE pathway serves a key role in protection against HIRI in mice (8, 27, 28) . However, whether the Nrf2/ARE pathway also contributes to the protection provided by BAI against HIRI remains unclear. The present study investigated the role of the Nrf2/ARE pathway in the protection effect provided by BAI against HIRI and its underlying mechanism. (29) . The midline incision of the upper abdomen was performed to separate and expose the hepatic portal. The branches of the left and middle portal veins and hepatic arteries were clipped using a non-invasive vascular clamp, resulting in 70% warm ischemia. The color of the liver lobe in the blocked area changed from bright red to pale white, indicating successful induction of hepatic ischemia. After 60 min, the clamp was released and blood flow was restored. In the Sham and BAI (100 mg/kg) groups, only the liver was exposed and blood flow was not blocked. After 1, 6 and 24 h reperfusion, mice were anesthetized via inhalation of 3% isoflurane for 3-5 min and 0.8-1 ml blood samples from the inferior vena cava and liver tissue were collected. Following blood collection, all mice were euthanized in a closed chamber via inhalation of 5% volatile isoflurane for 10 min. Mouse death was confirmed by cessation of heartbeat and nerve reflex. The procedure is shown in Fig. 1B . Statistical analysis. SPSS 13.0 (SPSS, Inc.) and GraphPad Prism 5.0 software (GraphPad Software, Inc.) were used for statistical analysis and presentation of the data. Shapiro-Wilk test confirmed that data were normally distributed. The data are presented as mean ± SD of at least three replicates. One-or two-way ANOVA followed post hoc Tukey's or Holm-Sidak test, respectively, were performed for multiple group comparisons. Two-sided P<0.05 was considered to indicate a statistically significant difference.

Liver

BAI ameliorates liver injury induced by IR. The activity of ALT and AST in serum and histological examination were used to assess liver injury. Levels of AST and ALT in the IR group were significantly increased, indicating impaired liver function ( Fig. 2A and B) . Serum ALT and AST levels were significantly decreased by pre-treatment with medium-and high-dose BAI (50 and 100 mg/kg) before IR, which indicated that BAI exerted a significant protective effect on liver func- tion. Consistent with the alterations in serum ALT and AST levels, compared with the Sham and BAI (100 mg/kg) group, a larger necrotic area was observed in the IR group by HE staining (Fig. 2C) . Compared with the I/R group, pre-treatment with medium-and high-dose BAI (50 and 100 mg/kg) before IR significantly decreased liver necrosis. Pathological results were verified by Suzuki score (Fig. 2D ). Suzuki scores indicated that the average injury level in the I/R group was significantly higher than that in the Sham and BAI (100 mg/kg) groups. However, compared with the I/R group, the BAI (50 mg/kg) + IR and BAI (100 mg/kg) + IR groups showed significant alleviation of average injury levels, while there was no significant difference between injury levels in the I/R and BAI (10 mg/kg) + IR groups. Following reperfusion (1, 6 and 24 h), pre-treatment with BAI significantly decreased the levels of ALT and AST ( Fig. 2E and F) compared with the corresponding IR group. These results suggested that BAI protected the liver from HIRI.

BAI decreases oxidative stress and hepatic apoptosis following HIRI. The aforementioned results indicated that medium-and high dose BAI (50 and 100 mg/kg) had protec-tive effects on HIRI and 100 mg/kg had a better protective effect. The levels of ALT and AST peaked at 6 h after IR; therefore, this time point was selected for subsequent experiments. To determine the protective effect of 100 mg/kg BAI, both blood and liver tissue samples from the Sham, BAI (100 mg/kg), IR and BAI (100 mg/kg) + IR groups were used for further study. To assess the effect of BAI on oxidative damage to the liver, liver tissue was stained with DHE probe to detect liver ROS content. Compared with the Sham and BAI (100 mg/kg) groups, IR liver tissue samples showed notably higher expression levels of intracellular ROS (Fig. 3A) . Pre-treatment with BAI suppressed ROS levels.

Pre-treatment with BAI (100 mg/kg) before IR significantly decreased liver cell apoptosis compared with the IR group ( Fig. 3B and C) . Moreover, compared with the Sham and BAI (100 mg/kg) groups, the MDA content in liver tissue of the IR group was significantly increased; this was downregulated significantly by BAI (100 mg/kg) pre-treatment (Fig. 3D) . By contrast to MDA, the activity of SOD in liver tissue was decreased significantly in the IR group compared with the Sham group (Fig. 3E) . Pre-treatment with BAI increased the activity of SOD in liver tissue independently of IR. BAI upregulates Nrf2/ARE pathway protein expression levels in liver. Western blotting was used to detect the expression levels of Nrf2/ARE pathway-associated protein. Compared with the Sham group, the expression levels of Nrf2 nucleoprotein and total HO-1 and NQO-1 protein increased significantly in the IR and BAI (100 mg/kg) groups ( Fig. 4A and B) . Compared with the IR group, the expression levels of Nrf2 nucleoprotein and total HO-1 and NQO-1 protein in the BAI (100 mg/kg) + IR group were further increased following pre-treatment with BAI. However, there was no significant difference in the expression levels of Nrf2 nucleoprotein and total HO-1 and NQO-1 protein between the IR and BAI (100 mg/kg) groups.

To confirm the role of the Nrf2/ARE pathway in BAI-treated mice following HIRI, the Nrf2 inhibitor ML385 was used. Compared with the IR group, the levels of Nrf2 nucleoprotein and total HO-1 and NQO-1 protein in the ML385 + IR group decreased significantly (Fig. 5A and B) . Moreover, compared with the BAI 100 mg/kg+ IR group, the expression of Nrf2 nucleoprotein and total HO-1 and NQO-1 protein in the ML385 + BAI (100 mg/kg) + IR group was significantly decreased. ML385 also aggravated liver injury (Fig. 5C , F and G), hepatocyte apoptosis ( Fig. 5F and H) and oxidative stress injury (Fig. 5D-F) . These data suggested that the Nrf2/ARE pathway served a significant role in the protective effect of BAI against HIRI.

BAI is the most abundant flavonoid in S. baicalensis and a key component of traditional Chinese medicine (31) . Previous studies have shown that BAI attenuates HIRI via inhibition of the NF-κB pathway and induction of autophagy (22, 23) .

Here, BAI pre-treatment significantly attenuated HIRI. BAI significantly decreased the elevated levels of AST and ALT and ameliorated the necrotic area of hepatocytes induced by HIRI. Additionally, pre-treatment with BAI inhibited oxidative damage and hepatocyte apoptosis. Pre-treatment with BAI promoted activation of the Nrf2/ARE pathway and alleviated liver injury during HIR, while Nrf2 inhibitor ML385 partially reversed the protective effect of BAI on HIRI. The present data indicated that BAI served a protective role in HIRI by regulating the Nrf2/ARE pathway to alleviate oxidative damage.

Multiple factors are involved in the occurrence and development of HIRI, such as oxygen free radical production, cell apoptosis, inflammatory reaction and calcium overload (32, 33) . Oxidative stress induced by large amounts of ROS during reperfusion not only serves an important role in the early stage of hepatocyte injury but also participates in the later stage of inflammation (1) . Excessive ROS beyond the clearance capacity of the liver damage lipids and proteins in cells, leading to cell death (34) . The present results showed that the levels of ALT and AST in serum were increased following HIRI. Histological examination revealed that HIRI resulted in hepatocyte apoptosis, congestion and necrosis. This damage may be due to the formation of lipid peroxides by combination of excessive ROS and lipids in the cell membrane, resulting in destruction of the hepatocyte membrane (35, 36) . The end product of lipid peroxides is MDA, which reflects the degree of cell peroxidation (37) . SOD scavenges free radicals, which decreases oxidative damage caused by IR (38) . BAI exhibits a well-known antioxidant capacity (39). Dong et al (10) found that BAI alleviates liver oxidative damage induced by high-level glucose. Pre-treatment with BAI increased the activity of SOD and decreased levels of ROS and MDA in liver tissue. Furthermore, pre-treatment with BAI significantly decreased the elevated levels of AST and ALT and ameliorated the necrotic area of hepatocytes induced by HIRI. These results showed that the protective effect of BAI against HIRI was mediated by alleviating oxidative damage to the liver.

The underlying mechanism of HIRI is complicated and not fully understood. Our previous study showed that [D-Ala2, D-Leu5]-Enkephalin significantly inhibits HIR-induced oxidative stress by activation of the Nrf2/HO-1 pathway (27) . Numerous endogenous antioxidant protection genes, such as SOD (25) and phase II detoxification enzymes, such as HO-1, are regulated by the Nrf2/ARE pathway (40) . HO-1 and NQO-1 are two widely studied phase II enzymes regulated by Nrf2 that serve an important role in antioxidation (38, 41) . Qin et al revealed that some hepatic metabolic enzyme genes of the Nrf2/ARE pathway, such as NQO1 and HO-1, were activated in BAI-treated hepatocytes (42) . Shi et al also demonstrated that pre-treatment with BAI activates the Nrf2/ARE pathway to alleviate acetaminophen-induced oxidative damage (43) . Kim et al (44) reported that baicalin alleviates liver IR injury by upregulating HO-1 expression. At the same time, baicalin serves an anti-inflammatory and antiapoptotic role by inhibiting activation of NF-κB and caspases 3 and 8 (44) . Baicalin and BAI are primary flavonoids extracted from the dry roots of S. baicalensis (45) . The molecular formula of BAI is C 15 H 10 O 5 , while that of baicalin is C 21 H 18 O 11 . The two molecules have similar pharmacological effects, such as anti-inflammatory, antioxidant and antiapoptotic effects. Qin et al (31) showed that BAI positively regulates the Nrf2/Kelch-like ECH-associated protein 1 (Keap1) pathway via Keap1-independent and -dependent pathways. In accordance with previous studies (9, 27) , HIR lead to an increase in expression levels of Nrf2 nucleoprotein and total HO-1 and NQO-1 protein, which indicated that the antioxidant pathway was activated when the liver was subjected to IR. Moreover, pre-treatment with BAI further increased the expression levels of Nrf2 nucleoprotein and downstream antioxidative enzymes, such as SOD, HO-1 and NQO-1. These results indicated that pre-treatment with BAI promoted Nrf2 nuclear translocation and increased the antioxidant capacity of the liver. The protective role of BAI in HIRI was disrupted by the Nrf2 inhibitor ML385, which supported the key role of Nrf2/ARE in BAI-provided protection against HIRI.

Several S. baicalensis-derived mixtures or pure compounds have been approved as clinical therapeutic drugs in China; for example, BAI capsules are used to treat hepatitis (46) . Hepatitis patients often develop liver cancer, and these patients with liver cancer and hepatitis often need extensive hepatectomy (47) . HIRI is a common pathological process occurring in extensive hepatectomy (1) . Therefore, it is worth studying whether BAI can be used before surgery in patients with hepatitis related liver cancer to decrease ischemia-reperfusion injury, as it is not only able to decrease ischemia-reperfusion injury, but also to decrease the adverse effect of hepatitis on the perioperative period. Nevertheless, there are certain limitations to the present study. The role of Keap1, an endogenous inhibitor of Nrf2, was not investigated. The dose selection of BAI was based on previous research (22) . The maximum dose of BAI was 100 mg/kg, which exhibited the most notable protective effect. Whether a higher BAI dose has a better protective effect requires further study. Based on the pharmacokinetics of BAI in vivo, the time and frequency of preoperative BAI should also be investigated in future.

The present findings showed that alleviation of oxidative stress by regulating the Nrf2/ARE pathway contributed to the protective effect of BAI against HIRI and BAI may be a promising therapeutic drug for the management of HIRI.

Ischaemia-reperfusion injury in liver transplantation -from bench to bedside

Liver ischaemia and reperfusion injury

Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation

Current knowledge on oxidative stress in hepatic ischemia/reperfusion

Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species

Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury

Ethanol, oxidative stress, and cytokine-induced liver cell injury

Immune-responsive gene 1/itaconate activates nuclear factor erythroid 2-related factor 2 in hepatocytes to protect against liver ischemia-reperfusion injury

Sulforaphane reduces apoptosis and oncosis along with protecting liver injury-induced ischemic reperfusion by activating the Nrf2/ARE pathway

Baicalein Alleviates Liver Oxidative Stress and Apoptosis Induced by High-Level Glucose through the Activation of the PERK/Nrf2 Signaling Pathway

Scutellaria baicalensisInhibitory Effects of Root Extract on Linoleic Acid Hydroperoxide-induced Lung Mitochondrial Lipid Peroxidation and Antioxidant Activities

Enhancement of Protective Effects of Radix Scutellariae on UVB-induced Photo Damage in Human HaCaT Keratinocytes

Anti-inflammatory effects of Baicalin, Baicalein, and Wogonin in vitro and in vivo

Study of the chemical composition and antimicrobial activities of ethanolic extracts from roots of Scutellaria baicalensis Georgi

Baicalein inhibits cell development, metastasis and EMT and induces apoptosis by regulating ERK signaling pathway in osteosarcoma

The effects of baicalein and baicalin on mitochondrial function and dynamics: A review

Baicalin Attenuates Alcoholic Liver Injury through Modulation of Hepatic Oxidative Stress, Inflammation and Sonic Hedgehog Pathway in Rats

Baicalin Attenuates High Fat Diet-Induced Obesity and Liver Dysfunction: Dose-Response and Potential Role of CaMKKβ/AMPK/ACC Pathway

Treatment with baicalein attenuates methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats

Antifibrotic effects of chronic baicalein administration in a CCl4 liver fibrosis model in rats

Baicalein selectively induces apoptosis in activated lymphocytes and ameliorates concanavalin a-induced hepatitis in mice

Baicalein pretreatment protects against liver ischemia/reperfusion injury via inhibition of NF-κB pathway in mice

Baicalein pretreatment reduces liver ischemia/reperfusion injury via induction of autophagy in rats

Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease

Effects of the Nrf2 Protein Modulator Salvianolic Acid A Alone or Combined with Metformin on Diabetes-associated Macrovascular and Renal Injury

Salvianolic acid A protects RPE cells against oxidative stress through activation of Nrf2/HO-1 signaling

DADLE improves hepatic ischemia/reperfusion injury in mice via activation of the Nrf2/HO-1 pathway

The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update

The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion

Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine

Baicalein modulates Nrf2/Keap1 system in both Keap1-dependent and Keap1-independent mechanisms

Vagus Nerve Stimulation Attenuates Hepatic Ischemia/Reperfusion Injury via the Nrf2/HO-1

Protective effect of ulinastatin on hepatic ischemia reperfusion injury through autophagy activation in Chang liver cells

Oxidative Stress and Inflammation in Hepatic Diseases: Current and Future Therapy

Hepatic Ischemia/Reperfusion: Mechanisms of Tissue Injury, Repair, and Regeneration

Dimethyl fumarate and curcumin attenuate hepatic ischemia/reperfusion injury via Nrf2/HO-1 activation and anti-inflammatory properties

Malondialdehyde, a lipid-derived aldehyde alters the reactivity of Cys34 and the esterase activity of serum albumin

Protective Effects of Chlorogenic Acid on Cerebral Ischemia/Reperfusion Injury Rats by Regulating Oxidative Stress-Related Nrf2 Pathway

Exploring the chemopreventive properties and perspectives of baicalin and its aglycone baicalein in solid tumors

Britanin Ameliorates Cerebral Ischemia-Reperfusion Injury by Inducing the Nrf2 Protective Pathway

NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger

Gene expression profiling and pathway network analysis of hepatic metabolic enzymes targeted by baicalein

Baicalein and baicalin alleviate acetaminophen-induced liver injury by activating Nrf2 antioxidative pathway: The involvement of ERK1/2 and PKC

Protective effects of baicalin against ischemia/reperfusion injury in rat liver

The Effects of Baicalin and Baicalein on Cerebral Ischemia: A Review

Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro

Prevention of hepatitis B recurrence after living donor liver transplantation: Primary high-dose hepatitis B immunoglobulin monotherapy and rescue antiviral therapy

Not applicable.

The present study was supported by the National Natural Science Foundation of China (grant nos. 91949122

The authors declare that they have no competing interests.